Analysts’ expectations for Verona Pharma Plc ADR (VRNA) stock: $113.6 price target in 12 months
At the time of writing, Verona Pharma Plc ADR [VRNA] stock is trading at $104.77, up 20.62%. An important factor to consider is whether the
At the time of writing, Verona Pharma Plc ADR [VRNA] stock is trading at $104.77, up 20.62%. An important factor to consider is whether the
At the time of writing, Corvus Pharmaceuticals Inc [CRVS] stock is trading at $4.18, up 5.56%. It is a good measure of the stock’s recent
At the time of writing, Ventyx Biosciences Inc [VTYX] stock is trading at $2.4, up 15.38%. One of the good ways to gauge the recent
At the time of writing, CytomX Therapeutics Inc [CTMX] stock is trading at $2.49, up 3.75%. In order to assess the stock’s recent performance, you
At the time of writing, Allurion Technologies Inc [ALUR] stock is trading at $2.86, up 10.42%. Until recently, the best way to gauge how the
At the time of writing, UP Fintech Holding Ltd ADR [TIGR] stock is trading at $10.22, up 3.34%. An important factor to consider is whether
At the time of writing, Palladyne AI Corp [PDYN] stock is trading at $8.5, up 0.95%. It is a good measure of the stock’s recent
At the time of writing, 89bio Inc [ETNB] stock is trading at $10.56, up 6.18%. One of the good ways to gauge the recent performance
At the time of writing, Capricor Therapeutics Inc [CAPR] stock is trading at $11.42, up 12.29%. In order to assess the stock’s recent performance, you
At the time of writing, Adaptimmune Therapeutics Plc ADR [ADAP] stock is trading at $0.28, up 9.01%. Until recently, the best way to gauge how
MZP News is your source for exclusive news, articles, and more. Launched in 2010, we’re growing with reader contributions like stories, photos, and tips! Share your finds and be part of our vibrant online community.
Copyright© 2024, Powered by Smart TechOne